Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_assertion type Assertion NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_head.
- NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_assertion description "[Considering only those patients with cerebral toxoplasmosis from whom CSF was collected before or during the first week of antitoxoplasmic therapy, sensitivity rose to 50%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_provenance.
- NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_assertion evidence source_evidence_literature NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_provenance.
- NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_assertion SIO_000772 8958252 NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_provenance.
- NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_assertion wasDerivedFrom befree-20150227 NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_provenance.
- NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_assertion wasGeneratedBy ECO_0000203 NP330866.RAVrPazt7PG0D37giw11JsfCy5njCvd_h_-R7I1tiPkmM130_provenance.